Top Markets
Coin of the day
Notable Labs, Ltd. Notable Labs, Ltd.

Notable Labs, Ltd.

NTBL
Rank in Stocks #41089
Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company,... Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company, concentrating on creating predictive, personalized treatments for individuals battling cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), the company virtually tests potential cancer therapies to forecast an individual patient's likely response to a specific drug. The primary goal of the PPMP is to identify and qualify patients who are expected to respond favorably before they even begin treatment, thereby significantly accelerating the clinical development process for these specific patient groups. Notable Labs' current development pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor designed to treat acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes. Additionally, it features Fosciclopirox, a prodrug of ciclopirox, also aimed at acute myeloid leukemia. The company's headquarters are located in Foster City, California.
Share Price
$0.0202
Last synced: 2024-11-19
Market Cap
$44.67K
Change (1 day)
-0.49%
Change (1 year)
0.00%
Country
IL
Trade Notable Labs, Ltd. (NTBL)

Category

Number of shares outstanding for Notable Labs, Ltd. (NTBL)
Number of shares outstanding as of June 2024: 9.46M
According to Notable Labs, Ltd. latest financial reports and stock price the company's current number of shares outstanding is 9.46M. At the end of December 2022 the company had 2.22M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Notable Labs, Ltd. (NTBL) from 2015 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
2026 (TTM) 9.46M 322.17%
2023 2.24M 1.08%
2022 2.22M -96.97%
2021 73.05M 44.56%
2020 50.53M 0.00%
2019 50.53M 53.27%
2018 32.97M 20.33%
2017 27.40M 9.72%
2016 24.97M 22.95%
2015 20.31M 0.00%
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
253.90M 2,585.14%
US
62.19M 557.65%
NL
- -
CH
- -
KR
0.00 -100.00%
BE